Abstract:OBJECTIVE:To study the inhibitory effect of small interference RNA (siRNA) targeting cyclin A2 gene on the growth of osteosarcoma MG-63 and human normal skin fibroblast HSF cells and to explore whether cyclin A2 siRNAs could become a useful tool in the treatment of osteosarcoma.METHODS:Three pairs of siRNAs targeting cyclin A2 mRNA and a pair of nonsense siRNA were designed according to the current criteria. SiRNAs were chemically synthesized and purified. The siRNAs were transfected into MG-63 cells and HSF cells via oligofectamine. The cells transfected with nonsense siRNA served as negative control group and those only treated with PBS as blank control group. Quantitative fluorescence RT-PCR, Western-blot, MTT assay, reverse transcriptase (RT)-PCR, flow cytometry and clone forming test were employed to evaluate the efficacy of RNA interference. At the same time, the mRNA expression of PCNA and cyclin B1 in siRNA-treated MG-63 cells were examined.RESULTS:Although all three siRNAs could reduce the cyclin A2 expression, siRNA, appeared to be the most effective. After 48 h treatment with siRNA1, cyclin A2 mRNA and protein expression in MG-63 cells was significantly reduced by nearly 80% as compared with that of the blank control group, whereas the negative and blank control groups had similar expression levels. MG-63 cells treated with siRNA1 were arrested at G0/G1 phase by 80.1% and the proliferation of these tumor cells was suppressed 48 h after transfection. Furthermore, MG-63 cells showed a decreased colony forming ability after siRNA1 treatment. In addition, the cyclin A2-depleted MG-63 cells showed decreased levels of PCNA and cyclin B1. In contrast, although cyclin A2 expression in HSF reduced by nearly 60% after treatment by siRNA1 for 48h, these cells exhibited only a slight change in cell cycling, and neither clear inhibition of proliferation nor impaired colony forming ability was observed.CONCLUSION:Cyclin A2 is critical for proliferation of MG-63 cells. Cyclin A2-siRNAs can induce obvious inhibition of cyclin A2 mRNA and protein expression in MG-63 and HSF cells, which consequently down-regulate the proliferation of MG-63 cells. There is little effect on the proliferation of siRNA-treated HSF cells. Those results indicate that siRNAs against cyclin A2 may become a potential antiproliferative tool in future antitumor therapy.

Effects of Argonaute Subfamily Proteins on Cell Cycle of Human Cancer Cells

Essential and Overlapping Functions for Mammalian Argonautes in Microrna Silencing.

Overexpression of Human Argonaute2 Inhibits Cell and Tumor Growth

Effects of Lncrna ANRIL-knockdown on the Proliferation, Apoptosis and Cell Cycle of Gastric Cancer Cells.

Argonaute Proteins: Potential Biomarkers for Human Colon Cancer

The Expanding Roles of Argonautes: RNA Interference, Splicing and Beyond

Argonaute 1 Regulates The Fate Of Germline Stem Cells In Drosophila

Ago1 Interacts with Rna Polymerase Ii and Binds to the Promoters of Actively Transcribed Genes in Human Cancer Cells

Small Interfering RNA Inhibits Cell Proliferation in Gastric Cancer Cell Lines Highly Expressing RegIα

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

Research Advances in Argonaute Proteins

Abstract 3776: HnRNP A1 Regulates Cell Cycle and Proliferation in Oral Squamous Cancer Cells

Argonaute Proteins: From Structure to Function in Development and Pathological Cell Fate Determination

Molecular Cloning and Expression Profiles of Argonaute Proteins in Schistosoma Japonicum.

Cell Cycle Regulation by Alternative Polyadenylation of CCND1.

Structural Evolution and Functional Diversification Analyses of Argonaute Protein

Loss of Lamin A leads to the nuclear translocation of AGO2 and compromised RNA interference

An Argonaute Phosphorylation Cycle Promotes Microrna-Mediated Silencing

Oral Squamous Cancer Cell Exploits Hnrnp A1 to Regulate Cell Cycle and Proliferation

Effect of targeted RNA interference of c-Abl/Arg non-receptor kinase on cell cycle